BARECETAMAB

UNII:	M9SE4M9U1V
Formula:
Preferred Substance Name:	BARECETAMAB
GSRS Full Record:	M9SE4M9U1V i

2275727-74-5
BARECETAMAB [INN]
BARECETAMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER3) (HUMAN MONOCLONAL ISU104 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ISU104 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS ERBB3 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3, HER3)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-451) (VH (HOMO SAPIENS IGHV3-23*01 (90.8%)-(IGHD)-IGHJ4*01 (100%)) CDR-IMGT (8.8.14) (26-33.51-58.97-110) (1-121)-HOMO SAPIENS IGHG1*01, NG1M1, G1M17 (CH1 K120 (218) (122-219), HINGE 1-15 (220-234), CH2 (235-344), CH3 E12 (360), M14 (362) (345-449), CHS (450-451)) (122-451)), (224-215')-DISULFIDE WITH LAMBDA LIGHT CHAIN HOMO SAPIENS (1'-216') (V-LAMBDA (HOMO SAPIENSIGLV1-47*02 (92.9%)-IGLJ2*01 (100%)) CDR-IMGT (8.3.11) (26-33.51-53.90-100) (1'-110')-HOMO SAPIENS IGLC3*03 (100%) (111'-216')); DIMER (230-230'':233-233'')-BISDISULFID
ISU104
ISU-104

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BARECETAMAB

Synonyms and Mappings

Resources